Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone effects on endothelial function and myocardial efficiency in obese insulin-resistant adults
2004-003861-34Phase 4Completed
- Sponsor
- Department of Nuclear Medicine
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pioglitazone in insulin resistance (IR) and obesity, sponsored by Department of Nuclear Medicine. Primary endpoints: Endothelial function in macrocirculation, Endothelial function in microcirculation and 2 more. Started Apr 2005; status: completed.
02
Drugs
pioglitazone
03
Conditions
insulin resistance (IR)obesity
Beyond the preview
Go deeper on 2004-003861-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003861-34.